Pfizer ended a Phase III trial for its experimental lung-cancer drug and said two studies of its advanced breast-cancer drug failed to meet their primary endpoints.
WSJ.com: What's News US, Wall Street Journal
Fri, 03/12/2010 - 7:01am
Pfizer ended a Phase III trial for its experimental lung-cancer drug and said two studies of its advanced breast-cancer drug failed to meet their primary endpoints.